Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Common Equity: 2018

Historic Common Equity for DiaMedica Therapeutics (DMAC) over the last 1 years, with Dec 2018 value amounting to $17.0 million.

  • DiaMedica Therapeutics' Common Equity rose 136.01% to $9.7 million in Q3 2019 from the same period last year, while for Sep 2019 it was $9.7 million, marking a year-over-year increase of 136.01%. This contributed to the annual value of $17.0 million for FY2018, which is N/A change from last year.
  • Latest data reveals that DiaMedica Therapeutics reported Common Equity of $17.0 million as of FY2018.
  • DiaMedica Therapeutics' 5-year Common Equity high stood at $17.0 million for FY2018, and its period low was $17.0 million during FY2018.
  • For the 1-year period, DiaMedica Therapeutics' Common Equity averaged around $17.0 million, with its median value being $17.0 million (2018).